Crossmark

Efficacy and safety of prophylaxis with emicizumab in hemophilia A: a study of 13 patients

Crossref DOI link: https://doi.org/10.1016/j.medcle.2023.07.027

Published Print: 2024-02

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Ocaña Gómez, M. Ángeles

Ferrer Machín, Alejandro

Vera Cabrera, Martín

Álvarez Tosco, Karen Ilenia

Ríos de Paz, Mario

De Dios García, M. Dolores
License Information

Text and Data Mining valid from 2024-02-01

stm-asf valid from 2024-02-01

stm-asf valid from 2024-02-01

stm-asf valid from 2024-02-01

stm-asf valid from 2024-02-01

stm-asf valid from 2024-02-01
More Information

This article is maintained by: Elsevier

Article Title: Efficacy and safety of prophylaxis with emicizumab in hemophilia A: a study of 13 patients

Journal Title: Medicina Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medcle.2023.07.027

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.medcli.2023.07.024

Content Type: article

Copyright: © 2023 Elsevier España, S.L.U. All rights reserved.